Literature DB >> 22782446

Clinical and biological implications of the tumor microenvironment.

David Tarin1.   

Abstract

In normal tissues and organs, the activities of the constituent cells are strictly restricted to the tasks assigned to them during development. In addition they (with the exception of leukocytes) remain inflexibly confined to their territorial domains by regulatory interactions with their neighbors.This creates specialized local micro-environments in which structure and function are orderly, stable and tightly controlled by feed-back loops, within interacting regulatory networks.This system has considerable ability to adapt to changing conditions. In contrast, the microenvironment in regions where tumors are forming and expanding is characterized by progressive loss of specialized or differentiated cellular functions,disorderly molecular signals, and degeneration of microscopical organ structure. This, coupled with the traffic of cells into and out of the tumor, often culminates in local invasion and metastasis to other organs. The nature of these disturbed molecular and cellular interactions is, by definition,highly unstable and increasingly unpredictable as time passes.It also varies between different tumors, sometimes even leading to regression. However, systematic analysis of this dysfunction in the tumor microcosm, using multiple modern research techniques, has revealed that all actively growing primary and secondary neoplasms share an absolute dependency upon support from adjacent non-neoplastic cells of the host. This support, in turn, continuously depends upon dynamic interplay between tumor and host cell populations, via signaling molecules and surface receptors in the tumor microenvironment.Such interplay determines the fate of the growing neoplasm. Such information, described and evaluated in this article, provides important new insights into the etiology of carcinogenesis and how tumor growth, invasion and metastasis might be therapeutically arrested. The facts and concepts assembled below, regarding the cancer microenvironment, demonstrate how modern molecular findings reveal the impact of the wide range of cancer diseases upon the internal cellular, tissue and organ environments of the whole individual and how this applies to designing new work to improve human cancer diagnosis and treatment. The article discusses several specific types of experimentally-induced and clinically common cancers to derive principles useful for interpreting events in the tumor microenvironment,which apply to cancers in general and especially to human malignant disease.

Entities:  

Year:  2012        PMID: 22782446      PMCID: PMC3399064          DOI: 10.1007/s12307-012-0099-6

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  67 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Enzyme-directed assembly and manipulation of organic nanomaterials.

Authors:  Michael E Hahn; Nathan C Gianneschi
Journal:  Chem Commun (Camb)       Date:  2011-09-30       Impact factor: 6.222

Review 3.  The three R's of lung health and disease: repair, remodeling, and regeneration.

Authors:  Michael F Beers; Edward E Morrisey
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

4.  Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells.

Authors:  Philip K Lim; Sarah A Bliss; Shyam A Patel; Marcelo Taborga; Meneka A Dave; Larissa A Gregory; Steven J Greco; Margarette Bryan; Prem S Patel; Pranela Rameshwar
Journal:  Cancer Res       Date:  2011-02-22       Impact factor: 12.701

5.  Pulmonary bone marrow embolism following external cardiac massage.

Authors:  P H Carstens
Journal:  Acta Pathol Microbiol Scand       Date:  1969

Review 6.  Inappropriate gene expression in human cancer and its far-reaching biological and clinical significance.

Authors:  David Tarin
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

7.  Progressive loss of CD44 gene expression in invasive bladder cancer.

Authors:  T Sugino; H Gorham; K Yoshida; J Bolodeoku; V Nargund; D Cranston; S Goodison; D Tarin
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

8.  Immunohistochemical profile of invasive lobular carcinoma of the breast: predominantly vimentin and p53 protein negative, cathepsin D and oestrogen receptor positive.

Authors:  W Domagala; M Markiewski; R Kubiak; J Bartkowiak; M Osborn
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

9.  Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts.

Authors:  D Tarin; J E Price; M G Kettlewell; R G Souter; A C Vass; B Crossley
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

10.  Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors.

Authors:  Jeffrey B Wyckoff; Yarong Wang; Elaine Y Lin; Jiu-feng Li; Sumanta Goswami; E Richard Stanley; Jeffrey E Segall; Jeffrey W Pollard; John Condeelis
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

View more
  28 in total

Review 1.  Progress in refining the clinical management of cancer of unknown primary in the molecular era.

Authors:  Elie Rassy; Nicholas Pavlidis
Journal:  Nat Rev Clin Oncol       Date:  2020-04-29       Impact factor: 66.675

Review 2.  Musculoskeletal Metastasis from Primary Rectal Cancer: Series of Two Cases of a Very Rare Occurrence with a Short Literature Review.

Authors:  Sankalp Singh; Niharika Bisht; Richa Joshi; Prabha Shankar Mishra; Deepak Mulajker; Samir Gupta
Journal:  J Gastrointest Cancer       Date:  2019-12

3.  Chemical mapping of the colorectal cancer microenvironment via MALDI imaging mass spectrometry (MALDI-MSI) reveals novel cancer-associated field effects.

Authors:  R Mirnezami; K Spagou; P A Vorkas; M R Lewis; J Kinross; E Want; H Shion; R D Goldin; A Darzi; Z Takats; E Holmes; O Cloarec; J K Nicholson
Journal:  Mol Oncol       Date:  2013-09-14       Impact factor: 6.603

4.  Origin and pharmacological modulation of tumor-associated regulatory dendritic cells.

Authors:  Hua Zhong; Dmitriy W Gutkin; Baohui Han; Yang Ma; Anton A Keskinov; Michael R Shurin; Galina V Shurin
Journal:  Int J Cancer       Date:  2014-01-20       Impact factor: 7.396

5.  Cancer associated fibroblast: Mediators of tumorigenesis.

Authors:  Jennifer Alexander; Edna Cukierman
Journal:  Matrix Biol       Date:  2020-05-22       Impact factor: 11.583

6.  Tumor-associated macrophages promote tumor cell proliferation in nasopharyngeal NK/T-cell lymphoma.

Authors:  Yixiong Liu; Linni Fan; Yingmei Wang; Peifeng Li; Jin Zhu; Lu Wang; Weichen Zhang; Yuehua Zhang; Gaosheng Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

7.  Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer.

Authors:  Brook Chernet; Michael Levin
Journal:  J Clin Exp Oncol       Date:  2013

8.  Enzyme-directed assembly of a nanoparticle probe in tumor tissue.

Authors:  Miao-Ping Chien; Matthew P Thompson; Christopher V Barback; Ti-Hsuan Ku; David J Hall; Nathan C Gianneschi
Journal:  Adv Mater       Date:  2013-05-28       Impact factor: 30.849

Review 9.  Miniaturized pre-clinical cancer models as research and diagnostic tools.

Authors:  Maria Håkanson; Edna Cukierman; Mirren Charnley
Journal:  Adv Drug Deliv Rev       Date:  2013-12-01       Impact factor: 15.470

Review 10.  Anti-tumour strategies aiming to target tumour-associated macrophages.

Authors:  Xiaoqiang Tang; Chunfen Mo; Yongsheng Wang; Dandan Wei; Hengyi Xiao
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.